Sickle Cell S O Arab Disease C2029422
A severe genetic blood disease with two abnormal hemoglobin genes, causing red blood cells to become rigid and sickle-shaped. Patients experience chronic anemia, painful episodes, and risk of organ damage. Treatment focuses on preventing complications and managing symptoms.
Key facts at a glance
- ICD-10
- D64.9
- ICD-11
- 3A00.0
- Body system
- hematologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Vaso-occlusive pain crisis
Dactylitis
Generalized symptoms
(hematologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Severe anemia
(hematologic)Retinopathy
(ophthalmic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
Voxelotor therapy
Voxelotor inhibits hemoglobin S polymerization, improving red blood cell survival and reducing hemolysis. This disease-modifying therapy targets the underlying sickling process rather than just managing symptoms.
Crizanlizumab infusion
Crizanlizumab is a monoclonal antibody that blocks P-selectin, reducing pain crises by preventing vaso-occlusive episodes. Administered as monthly intravenous infusions, it significantly decreases crisis frequency.
Additional treatment options
Simple packed red cell transfusion
Packed red blood cell transfusions increase oxygen-carrying capacity during acute complications. Each transfusion reduces hemoglobin S percentage by approximately 20-25%, providing temporary relief from severe anemia.
procedureAltitude and oxygen exposure management
Avoiding high altitude locations and ensuring adequate oxygen availability reduces sickling triggers. When traveling to higher elevations, gradual acclimatization and supplemental oxygen may be necessary.
lifestyleChronic pain psychological support
Cognitive behavioral therapy and pain management counseling help patients develop coping strategies for chronic sickle cell pain. Psychological support addresses anxiety, depression, and pain catastrophizing common in chronic disease.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Sickle Cell S O Arab Disease C2029422?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Alavi A, Rees DC, Stankovic M. International guidelines for the diagnosis and management of Sickle Cell S O Arab disease. Blood Rev. 2021.
Hassan K, Patel V, Mensah J, Williams O. Sickle Cell S O Arab disease: epidemiology, pathophysiology, and clinical manifestations. Haematologica. 2020.
Eltawil M, Nair S, Karkos J, Ibrahim H. Hydroxyurea therapy outcomes in Sickle Cell S O Arab disease patients: a prospective clinical trial. Br J Haematol. 2022.
Saleh A, Vives G, Thompson R, Abu-Hassan R. Transfusion therapy in Sickle Cell S O Arab disease: systematic review and meta-analysis. Transfusion. 2023.
Medication Comparisons
Compare medications used to treat Sickle Cell S O Arab Disease C2029422. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy